BioCatalyst

NBI-1065890 — catalyst calendar

1 verified catalyst event(s) referencing NBI-1065890, each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02 (month)
in 4mo
ESTIMATED
 READOUT
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With
Phase 2 · Tardive Dyskinesia
 NBIX NEUROCRINE BIOSCIENCES INC NBI-1065890 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.